Needham Maintains Buy on ICU Medical, Raises Price Target to $187
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.
Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.